Elicio Therapeutics, Inc. (ELTX) reported Loss for full year of -$51.90 million
The company's earnings totaled -$51.90 million, or -$4.25 per share. This compares with -$35.20 million, or -$6.96 per share, last year.
Elicio Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$51.90 Mln. vs. -$35.20 Mln. last year.
-EPS: -$4.25 vs. -$6.96 last year.
For comments and feedback: editorial@rttnews.com